Prostatype Genomics AB manufactures, markets and sells the prognostic gene test Prostatype. It helps clinicians and patients to make correct treatment decisions. The company was founded in 2007 and is headquartered in Solna, Sweden.
The current price of PROGEN is 0.0620 SEK — it has increased by 12.73% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on OMXSTO exchange PROSTATYPE GENOMICS AB stocks are traded under the ticker PROGEN.
PROSTATYPE GENOMICS AB is going to release the next earnings report on May 23, 2024. Keep track of upcoming events with our Earnings Calendar.
Like other stocks, PROGEN shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade PROSTATYPE GENOMICS AB stock right from TradingView charts — choose your broker and connect to your account.
PROGEN reached its all-time high on Jan 8, 2021 with the price of 6.1178 SEK, and its all-time low was 0.0390 SEK and was reached on Dec 12, 2023. See other stocks reaching their highest and lowest prices.
As of Mar 29, 2024, the company has 5.00 employees. See our rating of the largest employees — is PROSTATYPE GENOMICS AB on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. PROSTATYPE GENOMICS AB EBITDA is −31.67 M SEK, and current EBITDA margin is −2.76 K%. See more stats in PROSTATYPE GENOMICS AB financial statements.